Traws Pharma appoints Charles Parker as Interim CFO, effective July 5, 2025, replacing Nora Brennan

Traws Pharma, Inc.

Nora Brennan resigns as Interim CFO effective July 5, 2025; no severance, will provide transition services as independent contractor through July 18.
Board appoints Charles Parker as Interim CFO effective July 5; he is a Director at Stout, a global advisory firm.
Parker has over two decades of biopharma finance experience, including $700M+ capital raises and multi-million dollar debt restructurings.
Compensation terms for Parker not yet finalized; disclosure expected when consulting agreement is completed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.